1Department of Anatomy, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Division of Molecular Medicine, Research
287-297.
Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 3National Centre for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Bangkok, Thailand, 4Cancer and Immunology Research Unit (CIRU), School of Medicine, Mae Fah Luang University, Chiang Rai, Thailand, 5Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 6Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 7Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
*Corresponding author: Thawornchai Limjindaporn E-mail: thawornchai.lim@mahidol.ac.th
Received 6 February 2026 Revised 25 February 2026 Accepted 3 March 2026 ORCID ID: http://orcid.org/0000-0001-5270-493X https://doi.org/10.33192/smj.v78i4.280320
All material is licensed under terms of the Creative Commons Attribution 4.0 International (CC-BY-NC-ND 4.0) license unless otherwise stated.
ABSTRACT
Objective: The aim of this study was to investigate the apoptotic gene expression profile and to identify the genes involved in apoptosis and ZIKV infection.
Materials and Methods: SH-SY5Y cell line was infected with ZIKV at an MOI of 5. The cells were stained with Annexin V and propidium iodide to determine apoptosis. A real-time polymerase chain reaction array was employed to determine the apoptotic gene expression profile in a ZIKV-infected SH-SY5Y cell line. Western blot analysis was performed to confirm the expression of BIRC3 in both SH-SY5Y and A549 cell lines. Knockdown of the BIRC3 was done in ZIKV-infected A549 cell line using BIRC3 -specific siRNA. The ZIKV production was measured by focus-forming unit assay.
Results: Apoptotic genes in both extrinsic and intrinsic pathways, such as TNF-α, TRAIL, FAS, CASP8, CASP9, and BIRC3, were found to be upregulated. The anti-apoptotic gene BIRC3 was selected and found to be upregulated at the protein level in both ZIKV-infected SH-SY5Y and ZIKV-infected A549 cell lines. Knockdown of the BIRC3 gene in ZIKV-infected A549 cell line decreased Zika virus NS1 protein expression and Zika virion production.
Conclusion: The upregulation of anti-apoptotic BIRC3 expression facilitates Zika virus infection.
Keywords: Apoptosis; BIRC3 gene; Zika virus infection (Siriraj Med J 2026;78(4):287-297)
INTRODUCTION
Zika virus (ZIKV) is a member of the Flavivirus genus within the Flaviviridae family. ZIKV was first isolated from a blood sample taken from a sentinel rhesus monkey living in the Zika forest of Uganda.1 The primary mode of ZIKV transmission is via the bite of infected Aedes species mosquitoes.2 Notably, the transmission of ZIKV differs from that of other arboviral infections in that it can be transmitted sexually and via vertical transmission from mother to fetus.3-5 The most severe consequence of ZIKV infection manifests in the developing fetus, with serious neurological complications, such as microcephaly, often observed in newborns.6,7 ZIKV infection is also associated with other developmental defects, including cutaneous manifestations8, sensorineural loss, vision impairment, and fetal death.9,10 ZIKV was reported to induce immune-mediated neurological manifestations in adults, which is known as Guillain-Barré syndrome.11 Given the seriousness of this infection, the World Health Organization (WHO) declared ZIKV a public health emergency of international concern in 2016.12
In vitro and in vivo studies demonstrated a connection among ZIKV-induced cell death, brain atrophy, and microcephaly in newborns.13,14 The involvement of apoptosis in the pathogenesis of ZIKV infection was previously investigated using various cell lines and ZIKV strains.15-18 ZIKV was shown to induce apoptotic cell death in vitro18-21, and in vivo by impairing the development of the central nervous system in non-human primates.22,23 The apoptosis process in ZIKV infection involves both cell death receptor and mitochondrial pathways.24,25 Notably, ZIKV promotes apoptosis in neural progenitor cells
partially via the induction of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).26 Moreover, ZIKV was reported to induce neuronal apoptosis via increased mitochondrial fragmentation.27
The balance between pro- and anti-apoptotic proteins is essential for maintaining cellular homeostasis in virus-infected cells. By way of example, inhibition of apoptosis may facilitate viral replication. Anti-apoptotic proteins, such as heat shock proteins in host cells, were previously shown to facilitate and promote viral replication.28-30 Clonal expansion of cloned cluster of differentiation 8+ (CD8+) T cells in human T-lymphotropic virus type 1 (HTLV1)-infected cells becomes resistant to tumor necrosis factor receptor superfamily member 6 (FAS)-mediated cell death, and requires overexpression of baculoviral IAP repeat-containing 3 (BIRC3).31 However, and in this context, inhibition of apoptosis may limit viral replication. BIRC3 inhibits hepatitis B infection by accelerating the ubiquitin-proteasome-mediated destruction of viral polymerase.32 BIRC3 protects the host by maintaining pulmonary tissue homeostasis in influenza infection, and an insufficient level of BIRC3 was reported to increase susceptibility to and mortality in influenza A virus infection.33
MATERIALS AND METHODS
The protocols for this study were approved by the Siriraj Institutional Review Board (SIRB) of the Faculty of Medicine Siriraj Hospital, Mahidol University (COA No. Si 919/2020), and by the Siriraj Biosafety Risk Management Taskforce (COA No. Si 2020-027).
Cell lines and virus
The human neuroblastoma SH-SY5Y cell line (American Type Culture Collection (ATCC) CRL-2266, CVCL_0019) and the human lung epithelial cell line A549 (ATCC CCL-185, CVCL_0023) were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco; Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco), 1% non-essential amino acid (NEAA) (Gibco), and 1.2% penicillin G-streptomycin antibiotic solution in a 37-degree Celsius (°C), 5% carbon dioxide (CO2), and humidified atmosphere. The Aedes albopictus clone C6/36 cell line (ATCC CRL-1660, CVCL_Z230) was cultured in L-15 media supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 10% tryptose phosphate broth. ZIKV was propagated in C6/36 cell line and these cells were maintained in a 28°C incubator. The Vero cell line (ATCC CCL-81, CVCL_0059) was cultured in Eagle’s minimal essential medium (MEM) supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. Those cells were subsequently maintained in a 5% CO2 humidified incubator at 37°C. ZIKV strain MU1-2017 was previously isolated at the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.34
ZIKV infection
SH-SY5Y and A549 cells were seeded into 12-well plates and infected with ZIKV at multiplicity of infections (MOIs) of 1 and 5. The cells were incubated at 37°C for 2 hours. The cells were then washed with PBS for 2 hours after incubation, after which the PBS was replaced with complete growth media for continued incubation. The cells and supernatants were collected at 24- and 48-hours post-infection (hpi). The percentage of ZIKV infection was then analyzed by flow cytometry. Briefly, SH-SY5Y and A549 cells were detached using 0.1% trypsin and washed with PBS. The cells were fixed with 4% paraformaldehyde in PBS for 20 minutes, followed by permeabilization with 0.2% Triton X-100 in PBS for 10 minutes. The cells were washed with PBS and stained with 4G2 at room temperature for 1 hour. After washing with PBS, the cells were stained with Alexa 488-conjugated goat anti-mouse IgG (Invitrogen Corporation, Carlsbad, CA, USA) at room temperature for 1 hour. The ZIKV-positive cells were evaluated using a BD Accuri C6 Plus flow cytometer (BD Biosciences, San Jose, CA, USA) and FlowJo software (FlowJo LLC, Ashland, OR, USA). The viral titer was determined by Focus-Forming Unit (FFU) assay in Vero cells and calculated based on foci staining of the E protein and reported as focus-forming units per
milliliter (FFU/ml).35 Cell viability was analyzed using the trypan blue exclusion assay.36
Immunofluorescence analysis
SH-SY5Y cells were grown on coverslips for 24 hours and infected with ZIKV at MOIs of 1 and 5. At 24 and 48 hpi, Cells were fixed and permeabilized with 4% paraformaldehyde in PBS for 20 minutes and 0.2% Triton X-100 in PBS for 10 minutes, respectively. The cells were then incubated with 4G2 for 1 hour, followed by the addition of a mixture of Cy3-conjugated goat anti-mouse IgG (Invitrogen) and Hoechst 33342 (Invitrogen) for nuclear staining at room temperature for 1 hour. Images were visualized using a laser-scanning confocal microscope (LSM800; ZEISS Microscopy, Jena, Germany).
Apoptosis assay
A total of 1×106 SH-SY5Y cells per well was seeded in a 6-well plate and cultured for 24 hours. The SH-SY5Y cells were infected with ZIKV at an MOI of 5 and incubated for 48 hours. Thereafter, the cells were stained with Annexin V and propidium iodide (PI) (ImmunoTools, Friesoythe, Germany) (37), followed by data acquisition using a BD Accuri C6 Plus flow cytometer (BD Biosciences). Post-acquisition data analysis was performed using FlowJo software (FlowJo, LLC). The apoptotic gene expression profile was identified using a real-time polymerase chain reaction array. Specifically, a human apoptosis RT2 profiler Real-time PCR array (Qiagen, Hilden, Germany), precoated with primers specific to 84 apoptosis-relevant genes, was used for the profiling. Ribonucleic acid (RNA) was extracted from both mock- and ZIKV-infected cells using the RNeasy Mini Kit (Qiagen). Five hundred
(500) nanograms (ng) of purified RNA (optical density [OD] 260 nm/OD 280 nm ≥2.0) was transcribed into complementary deoxyribonucleic acid (cDNA) using an RT2 First Strand Kit (Qiagen). Real-time PCR was performed using a Light-Cycler 480 instrument (Roche Life Science, Basel, Switzerland). For the real-time PCR, 640 ng of cDNA was mixed with RT2 qPCR Master Mix (Qiagen). The mixture was carefully aliquoted into each well of the array. The temperature profile was set at 95°C for 10 minutes, followed by 45 cycles of 95°C for 15 seconds, followed by 60°C for 1 minute. The threshold cycle (Ct) was calculated for each sample. Using the 2-ΔΔCt method38, the expression of apoptotic genes was expressed as the fold change between ZIKV-infected and mock samples. Beta-actin (β-actin) was used as a housekeeping gene in the comparison. Analysis was performed using a web-based program created and published by Qiagen (https://dataanalysis2.qiagen.com/pcr).
siRNA transfection
A549 cells were transfected with either BIRC3-specific siGENOME SMARTPool siRNAs for BIRC3 (M-004099-02-0010, Dharmacon, Inc., Lafayette, CO, USA) that targeted the position of reference BIRC3 gene sequence NM_001165.5, or control siGENOME non-targeting siRNA Pool #2 (D-001206-14-05, Dharmacon) using Lipofectamine RNAiMax (Invitrogen). The siRNA and Lipofectamine RNAiMAX complex were added to and incubated with A549 cells for 6 hours, followed by a switch to complete growth media. After knockdown for 24 hours, cells were infected with ZIKV at an MOI of 1 and incubated for 2 hours. After virus removal, the cells were washed and replaced with complete growth media. Mock- or ZIKV-infected and siRNA-transfected cells as well as culture supernatants were harvested at 48 hpi. To determine the efficiency of siRNA transfection, BIRC3 messenger ribonucleic acid (mRNA) and protein expression in the cells were measured using real-time PCR and Western blot analysis. ZIKV NS1 protein expression in the cells was determined by Western blot analysis. ZIKV production was assessed by FFU assay using culture supernatant.35
Real-time PCR
Total RNA was isolated from mock- and ZIKV-infected A549 cells that were transfected with control siRNA or BIRC3 siRNA. The SuperScript III First-Strand Synthesis System (Invitrogen) was used to synthesize cDNA from the isolated total RNA. The cDNA was amplified using a LightCycler 480 SYBR Green I Master Kit (Roche Life Science). The mixture for each reaction consisted of 3 µl of PCR grade water, 5 µl of 2× SYBR Green I Master Mix, 0.5 µl of forward primer, 0.5 µl of reverse primer, and 1 µl of cDNA. The nucleotide primers used were specific to BIRC3 (BIRC3_Forward 5’-AAGCTACCTCTCAGCCTACTT T-3’ and BIRC3_
Reverse5’-CCACTGTTTTCTGTACCCGGA-3’)andβ-actin (β-actin_Forward 5’-AGAAAATCTGGCACCACACC-3’ and β-actin_Reverse 5’-CTCCTTAATGTCACGCACGA-3’). The temperature profile included pre-incubation at 95°C for 5 minutes, followed by 50 cycles of denaturation at 95°C for 10 seconds, annealing at 60°C for 10 seconds, and extension at 72°C for 20 seconds. The Ct value of each selected gene was normalized to the Ct value of the β-actin housekeeping gene. The relative expression of genes (2-ΔΔCt) was analyzed by comparing the siRNA control group to siRNA specific to BIRC3.
Western blot analysis
SH-SY5Y and A549 cells were harvested at 48 hours
after ZIKV infection in the presence or absence of control or specific siRNA transfection. Cell pellets were lysed on ice for 30 minutes using radioimmunoprecipitation assay (RIPA) buffer, followed by centrifugation at 13,000 revolutions per minute (rpm) for 5 minutes at 4°C. After collection of the lysate, the protein concentration was measured using a Bradford protein assay (Bio-Rad Laboratories, Hercules, CA, USA). A total of 20-60 µg of protein was loaded, followed by separation via sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and blotting onto a nitrocellulose membrane. The membrane was blocked with 5% skim milk in PBS for 1 hour and washed three times. The membrane was then incubated with rabbit monoclonal antibody against BIRC3 or c-IAP2 (1:1000) (Cell Signaling Technology, Danvers, MA, USA), mouse anti-human ZIKV NS1 monoclonal antibody (1:1000) (Arigo Biolaboratories, Hsinchu City, Taiwan), or mouse anti- human GAPDH (1:1000) (Santa Cruz Biotechnology, Dallas, TX, USA) at 4°C overnight. After washing the membrane one time with PBS, HRP-conjugated goat anti-rabbit (Jackson ImmunoResearch, West Grove, PA, USA) or rabbit anti-mouse secondary antibody (Dako Denmark A/S, Glostrup, Denmark) was added onto the membrane and incubated at RT for 1 hour. Enhanced chemiluminescence (ECL) substrate was then added and the signal was visualized using plain radiographic film (X-ray). The quantity of protein was analyzed using ImageJ software (https:// imagej.nih.gov/ij; United States National Institutes of Health, Bethesda, MD, USA).
All statistical analyses were performed using GraphPad Prism 5 software (GraphPad Software, Inc., La Jolla, CA, USA). Data from three independent experiments are presented as the mean plus/minus (±) the standard error of the mean (SEM). The data were analyzed using either Student’s t-test or one-way analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison test. A probability (p) value less than 0.05 was regarded as being statistically significant.
RESULTS
SH-SY5Y cells were infected with ZIKV at MOIs of 1 and 5 or left uninfected (mock control) and then collected at 24 and 48 hpi. The percentage of ZIKV infection was analyzed by flow cytometry. Results showed that the infection rates of ZIKV at 24 and 48 hpi were approximately 26.86% and 56.47% for the MOI of 1 vs.
40.07% and 72.37% for the MOI of 5, respectively (Figs 1a and 1b). This was consistent with the proportion of ZIKV E-positive SH-SY5Y cells observed by a laser-scanning confocal microscopy (Fig 1c). While infection with the MOI of 1 did not affect cell viability at 24 and 48 hpi, infection with the MOI of 5 significantly reduced the viability of ZIKV-infected SH-SY5Y cells at 48 hpi (p<0.05) (Fig 1d).
Further analysis of apoptotic cells by Annexin V/ propidium iodide (PI) staining and flow cytometry demonstrated significantly higher prevalence of apoptosis in ZIKV-infected cells compared to the proportion observed in the mock-infected cells (32.7 % vs. 1.0 %, respectively; p<0.0001) (Fig 2b). A representative flow cytometric scatter plot of Annexin V/PI-stained cells is shown in Fig 2a.
Fig 1. ZIKA virus (ZIKV) infection in human neuroblastoma SH-SY5Y cells.
Fig 2. Annexin V/PI staining in the human neuroblastoma SH-SY5Y cells.
Representative of scatter plots of the flow cytometric analysis demonstrates the profile of Annexin V/PI staining for mock and ZIKV-infected SH-SY5Y cells. (b) Percentage of early apoptotic cells (Annexin V+/PI-) compared between mock and ZIKA virus (ZIKV)-infected SH-SY5Y cells from three independent experiments (***p<0.0001).
A human apoptosis RT2 profiler polymerase chain reaction array was used to profile gene expression in ZIKV-infected cells. The β-actin gene served as a housekeeping gene for normalizing the data. Of the 84 apoptosis-related genes, 61 were upregulated and 17 were downregulated in the ZIKV-infected SH-SY5Y cells. The mRNA expression of the top 20 upregulated genes is presented in Table 1. The expression levels of the BIRC3 and interleukin 10 (IL-10) genes were significantly upregulated in the ZIKV-infected SH-SY5Y cells, with 22.01-fold and 19.70-fold changes in expression, respectively – both compared to the mock-infected cells. Three crucial genes in the extrinsic pathway (TNF-α, TRAIL, and FAS) were upregulated with 13.55-fold, 12.82-fold, and 10.93-fold increases, respectively. Three key regulator genes of apoptosis
(CASP8, CASP9, and CASP3) were upregulated with 2.06-fold, 4.44-fold, and 1.33-fold increases, respectively.
The BIRC3 gene was selected for further analysis due to its highest upregulated mRNA expression in apoptotic gene expression profiling in ZIKV-infected SH-SY5Y cells. Verification of BIRC3 protein expression in SH-SY5Y cells was performed in parallel with that in human lung epithelial A549 cells, which is highly permissive to ZIKV infection. When the SH-SY5Y and A549 cells were infected with ZIKV at MOIs of 1 and 5 for 48 hours followed by Western blot analysis, BIRC3 protein was found to be upregulated in both ZIKV-infected A549 (Figs 3 a, b) and ZIKV-infected SH-SY5Y cells (Figs 3 a, c).
TABLE 1. Fold change of apoptotic gene expression in ZIKA virus-infected SH-SY5Y cells.
Gene no. | Fold change | Gene name | Gene description |
1 | 22.01 | BIRC3 | Baculoviral IAP repeat-containing 3 |
2 | 19.70 | IL10 | Interleukin 10 |
3 | 13.55 | TNF | Tumor necrosis factor |
4 | 12.82 | TNFSF10 | Tumor necrosis factor (ligand) superfamily, member 10 |
5 | 10.93 | FAS | Fas (TNF receptor superfamily, member 6) |
6 | 9.51 | CASP 10 | Caspase 10, apoptosis-related cysteine peptidase |
7 | 8.51 | CD27 | CD27 molecule |
8 | 8.11 | TNFRSF9 | Tumor necrosis factor receptor superfamily, member 9 |
9 | 5.86 | BAK1 | BCL2-antagonist/killer 1 |
10 | 5.82 | CASP 5 | Caspase 5, apoptosis-related cysteine peptidase |
11 | 5.28 | CASP 1 | Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) |
12 | 5.28 | CASP 14 | Caspase 14, apoptosis-related cysteine peptidase |
13 | 5.28 | CD40 | CD40 molecule, TNF receptor superfamily member 5 |
14 | 5.28 | FASLG | Fas ligand (TNF superfamily, member 6) |
15 | 4.79 | BAD | BCL2-associated agonist of cell death |
16 | 4.44 | CASP 9 | Caspase 9, apoptosis-related cysteine peptidase |
17 | 4.23 | RIPK2 | Receptor-interacting serine-threonine kinase 2 |
18 | 2.06 | CASP 8 | Caspase 8, apoptosis-related cysteine peptidase |
19 | 1.33 | CASP 3 | Caspase 3, apoptosis-related cysteine peptidase |
20 | 1.12 | BAX | BCL2-associated X protein |
Fig 3. Baculoviral IAP repeat-containing 3 (BIRC3) protein expression in ZIKA virus (ZIKV)-infected human neuroblastoma SH-SY5Y and human lung epithelial A549 cells.
Western blot analysis for BIRC3 expression in SH-SY5Y and A549 cell lines infected with ZIKV at MOIs of 1 and 5.
Densitometric analysis of Western blot results compared between ZIKV-infected A549 and mock control. (c) Densitometric analysis of Western blot results compared between ZIKV-infected SH-SY5Y and mock control (*p<0.05).
After several attempts failed to knock down BIRC3 in ZIKV-infected SH-SY5Y cells, we decided to conduct further experiments in ZIKV-infected A549 cells. Human A549 cells were transfected with control siRNA or BIRC3-specific siRNA for 24 hours and then infected with ZIKV at an MOI of 1 or left uninfected (mock). Knockdown
efficiency was examined by investigating both mRNA and protein expressions of BIRC3 at 48 hpi. We observed no adverse effect of siRNA transfection and ZIKV infection on cell viability of human A549 cells (Fig 4a). The siRNA knockdown of BIRC3 was successful under the tested conditions as evidenced by the significant reduction of BIRC3 at both mRNA level (Fig 4b) and protein level (Fig 4c).
Fig 4. Small interfering ribonucleic acid (siRNA)-mediated knockdown of the BIRC3 gene in mock- and ZIKV-infected human lung epithelial A549 cells.
Three independent experiments were performed. (a) Percentage of cell viability compared between control siRNA- and BIRC3 siRNA-transfected A549 cells in the presence or absence of ZIKV infection. (b) Relative expression of the mRNA expression of BIRC3 mRNA in mock- and ZIKV-infected A549 cells following siRNA knockdown (*p<0.05). (c) Western blot analysis of BIRC3 protein expression in mock- and ZIKV-infected A549 cells following siRNA knockdown. A representative of three independent experiments is shown (left panel). Relative expression of the BIRC3 protein expression in mock- and ZIKV-infected A549 cells following siRNA knockdown (**p<0.001,
***p<0.0001).
The effect on virion production and NS1 protein expression was examined at 48 hpi by focus forming unit (FFU) assay and Western blot analysis, respectively. We found a significant reduction in ZIKV production by approximately 70-80% in the BIRC3 knockdown cell cultures compared to that of control cell cultures (Fig 5a). In agreement with this finding, ZIKV NS1 protein expression was significantly decreased in ZIKV-infected cells following BIRC3 knockdown in a dose-dependent manner. These results suggest the role of BIRC3 in supporting ZIKV replication in human A549 cells (Fig 5b).
DISCUSSION
Importantly, the results of this study indicate that ZIKV infection induces apoptotic cell death.18-21 Previous studies demonstrated that ZIKV triggers neuronal cell death by activating extrinsic, intrinsic, or both apoptotic pathways.21,26,27 In this study, pro-apoptotic genes associated with the extrinsic apoptotic pathway, including TNF-α,
TRAIL, FAS, FASL, and CASP8, were upregulated in ZIKV-infected SH-SY5Y cell line. Moreover, apoptotic genes related to the intrinsic apoptotic pathway, including BAK, BID, and CASP9, were upregulated in the ZIKV-infected SH-SY5Y cell line. ZIKV infection was previously reported to induce apoptosis by modulating the recruitment and activation of the pro-apoptotic protein BAX.39 Both BAX and BAK are considered to be key members of B cell lymphoma-2 (BCL2) protein family, which plays a critical role in modulating apoptosis.40 Cellular inhibitors of apoptosis proteins (cIAPs), including BIRC2 and BIRC3, were found to be upregulated in ZIKV-infected SH-SY5Y cells in our study.
BIRC3 is a member of the inhibitor of apoptosis (IAP) family, and it was the first in that family shown and reported to inhibit cell death.41 BIRC3 is characterized by the presence of the baculoviral IAP repeat (BIR) domain, the ubiquitin-conjugating (UBC) domain, the caspase recruitment (CARD) domain, and the ring zinc finger (RING) domain.42 The BIRC3 gene was selected for further analysis in our study since it had the highest upregulated expression among any evaluated gene in apoptotic gene expression profiling. In addition, the
Fig 5. ZIKV NS1 protein expression and infectious ZIKV production in human lung epithelial A549 cells following ZIKV infection and siRNA knockdown.
protein expression of BIRC3 was found to be upregulated in both ZIKV-infected A549 and ZIKV-infected SH-SY5Y cell lines. After several attempts failed to knock down BIRC3 in ZIKV-infected SH-SY5Y cells, we decided to conduct further experiments in ZIKV-infected A549 cells. Interestingly, knockdown of BIRC3 in ZIKV-infected A549 cells impaired ZIKV production at 48 hpi without affecting cell viability. In addition, siRNA against BIRC3 reduced ZIKV NS1 protein expression. These results suggest an important role of BIRC3 to facilitate ZIKV replication. The mechanisms by which ZIKV uses host cell machinery via the upregulation of NF-kB-dependent anti-apoptotic proteins, such as BIRC3, for its own replication warrant further investigation. Human immunodeficiency virus 1 (HIV-1) also developed strategies to favor the persistent replication of HIV-1 in infected T cells. This developed protection was characterized by deregulation of proteins that stabilize mitochondrial membrane integrity, and by upregulation of nuclear factor kappa-light-chain-enhancer of activated B cells or nuclear factor-kB (NF-kB)-dependent anti-apoptotic proteins, such as BIRC3.43 Activated NF-kB is also a mechanism by which lymphoma cells infected by the Epstein-Barr virus or Kaposi’s sarcoma herpesvirus are protected from apoptotic stress.44 ZIKV NS2A and NS4A were previously shown to suppress NF-kB promoter activity by inhibiting signaling factors involved in the melanoma differentiation-associated protein 5 (MDA5)/retinoic acid-inducible gene I (RIG-I) signaling pathway.45 ZIKV delays cell death through the anti-apoptotic Bcl-2 family proteins.46 If this host cell protection is the mechanism by which BIRC3 promotes viral replication, whether downregulation of BIRC3 leads to alterations in the apoptotic process merits further investigation.
CONCLUSION
Significant upregulation of BIRC3 protein was detected in both human neuroblastoma SH-SY5Y and human lung epithelial A549 cells following ZIKV infection. Knockdown of the BIRC3 gene significantly decreased ZIKV NS1 protein expression and virion production in ZIKV-infected A549 cells without any adverse effect on cell viability. These findings suggest the involvement of BIRC3 in ZIKV replication and pathogenesis.
The data are available from the corresponding author upon request.
ACKNOWLEDGEMENTS
The authors gratefully acknowledge Dr. Sreekanth
Gopinathan Pillai from Manipal Institute of Virology, Manipal Academy of Higher Education, Manipal, Karnataka, India, and members of the Division of Molecular Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University for their technical support. We would like to thank Kevin
P. Jones for editing of the manuscript.
DECLARATIONS
T.L. was supported by Siriraj Research and Development Grant from the Faculty of Medicine Siriraj Hospital, Mahidol University (grant no: R016533001). A.P. was supported by Siriraj Graduate Thesis Scholarship from the Faculty of Medicine Siriraj Hospital, Mahidol University.
All authors declare no personal or professional conflicts of interest, and no financial support from the companies that produce and/or distribute the drugs, devices, or materials described in this report.
None.
Conceptualization and methodology, A.P., P.S., S.M., S.N., P.Y., and T.L. ; Investigation, A.P., P.S., P.R.,
S.M., and A.M. ; Formal analysis, A.P., P.S., P.R., S.M., and A.M. ; Writing – review and editing, A.P., P.S., S.M., S.N., and T.L. ; Resources, P.A., M.U., and C.P.
; Funding acquisition, T.L. All authors have read and agreed to the final version of the manuscript.
No form of artificial intelligence (AI) was used in this study.
REFERENCES
Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46(5): 509-20.
Medin CL, Rothman AL. Zika Virus: The Agent and Its Biology, With Relevance to Pathology. Arch Pathol Lab Med. 2017;141(1): 33-42.
Besnard M, Lastere S, Teissier A, Cao-Lormeau V, Musso D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill. 2014;19(13).
Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016;29(3): 487-524.
Mesci P, Macia A, Moore SM, Shiryaev SA, Pinto A, Huang CT, et al. Blocking Zika virus vertical transmission. Sci Rep. 2018; 8(1):1218.
Liang B, Guida JP, Costa Do Nascimento ML, Mysorekar IU.
Host and viral mechanisms of congenital Zika syndrome. Virulence. 2019;10(1):768-75.
Calvet G, Aguiar RS, Melo ASO, Sampaio SA, de Filippis I, Fabri A, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis. 2016;16(6):653-60.
Leeyaphan C, Tantrapornpong P. Cutaneous Manifestations and Associated Systemic Findings of Patients with Zika Infections. Siriraj Med J. 2020;72(4):321-9.
Brasil P, Pereira JP, Jr., Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro. N Engl J Med. 2016;375(24): 2321-34.
Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika Virus and Birth Defects--Reviewing the Evidence for Causality. N Engl J Med. 2016;374(20):1981-7.
Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531-9.
Gulland A. Zika virus is a global public health emergency, declares WHO. BMJ. 2016;352:i657.
Solomon IH, Milner DA, Folkerth RD. Neuropathology of Zika Virus Infection. J Neuroinfect Dis. 2016;7(2).
Chimelli L, Avvad-Portari E. Congenital Zika virus infection: a neuropathological review. Childs Nerv Syst. 2018;34(1):95-9.
Kim JA, Seong RK, Kumar M, Shin OS. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models. Viruses. 2018;10(2).
Goodfellow FT, Willard KA, Wu X, Scoville S, Stice SL, Brindley MA. Strain-Dependent Consequences of Zika Virus Infection and Differential Impact on Neural Development. Viruses. 2018;10(10).
Gabriel E, Ramani A, Karow U, Gottardo M, Natarajan K, Gooi LM, et al. Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids. Cell Stem Cell. 2017;20(3):397-406 e5.
Turpin J, El Safadi D, Lebeau G, Krejbich M, Chatelain C, Despres P, et al. Apoptosis during ZIKA Virus Infection: Too Soon or Too Late? Int J Mol Sci. 2022;23(3).
Rothan HA, Fang S, Mahesh M, Byrareddy SN. Zika Virus and the Metabolism of Neuronal Cells. Mol Neurobiol. 2019;56(4): 2551-7.
Souza BS, Sampaio GL, Pereira CS, Campos GS, Sardi SI, Freitas LA, et al. Zika virus infection induces mitosis abnormalities and apoptotic cell death of human neural progenitor cells. Sci Rep. 2016;6:39775.
Frumence E, Roche M, Krejbich-Trotot P, El-Kalamouni C, Nativel B, Rondeau P, et al. The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-beta production and apoptosis induction. Virology. 2016;493:217-26.
Li C, Xu D, Ye Q, Hong S, Jiang Y, Liu X, et al. Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice. Cell Stem Cell. 2016;19(1):120-6.
Martinot AJ, Abbink P, Afacan O, Prohl AK, Bronson R, Hecht JL, et al. Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys. Cell. 2018;173(5):1111-22 e10.
de Sousa JR, Azevedo RSS, Martins Filho AJ, Araujo MTF, Moutinho ERC, Baldez Vasconcelos BC, et al. Correlation
between Apoptosis and in Situ Immune Response in Fatal Cases of Microcephaly Caused by Zika Virus. Am J Pathol. 2018; 188(11):2644-52.
Ghosh Roy S, Sadigh B, Datan E, Lockshin RA, Zakeri Z. Regulation of cell survival and death during Flavivirus infections. World J Biol Chem. 2014;5(2):93-105.
Lee JK, Kim JA, Oh SJ, Lee EW, Shin OS. Zika Virus Induces Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL)-Mediated Apoptosis in Human Neural Progenitor Cells. Cells. 2020;9(11).
Yang S, Gorshkov K, Lee EM, Xu M, Cheng YS, Sun N, et al. Zika Virus-Induced Neuronal Apoptosis via Increased Mitochondrial Fragmentation. Front Microbiol. 2020;11:598203.
Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol. 2005;79(8):4557-67.
Srisutthisamphan K, Jirakanwisal K, Ramphan S, Tongluan N, Kuadkitkan A, Smith DR. Hsp90 interacts with multiple dengue virus 2 proteins. Sci Rep. 2018;8(1):4308.
Rothan HA, Zhong Y, Sanborn MA, Teoh TC, Ruan J, Yusof R, et al. Small molecule grp94 inhibitors block dengue and Zika virus replication. Antiviral Res. 2019;171:104590.
Zane L, Sibon D, Legras C, Lachuer J, Wierinckx A, Mehlen P, et al. Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression. Virology. 2010;407(2): 341-51.
Wang Z, Ni J, Li J, Shi B, Xu Y, Yuan Z. Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase. J Virol. 2011;85(21):11457-67.
Rodrigue-Gervais IG, Labbe K, Dagenais M, Dupaul-Chicoine J, Champagne C, Morizot A, et al. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe. 2014;15(1):23-35.
Jitsatja A, Ramphan S, Promma P, Kuadkitkan A, Wikan N, Uiprasertkul M, et al. Comparative analysis of a Thai congenital-Zika-syndrome-associated virus with a Thai Zika-fever-associated virus. Arch Virol. 2020;165(8):1791-801.
Dangsagul W, Ruchusatsawat K, Tawatsin A, Changsom D, Noisumdaeng P, Putchakarn S, et al. Zika virus isolation, propagation, and quantification using multiple methods. PLoS One. 2021;16(7):e0255314.
Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 2001;Appendix 3:Appendix 3B.
Rieger AM, Nelson KL, Konowalchuk JD, Barreda DR. Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J Vis Exp. 2011(50).
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8.
Han X, Wang J, Yang Y, Qu S, Wan F, Zhang Z, et al. Zika virus infection induced apoptosis by modulating the recruitment and activation of pro-apoptotic protein Bax. J Virol. 2021;95(8).
Cosentino K, Hertlein V, Jenner A, Dellmann T, Gojkovic M, Pena-Blanco A, et al. The interplay between BAX and BAK tunes apoptotic pore growth to control mitochondrial-DNA-mediated inflammation. Mol Cell. 2022;82(5):933-49 e9.
Clem RJ. Viral IAPs, then and now. Semin Cell Dev Biol.
2015;39:72-9.
Frazzi R. BIRC3 and BIRC5: multi-faceted inhibitors in cancer. Cell Biosci. 2021;11(1):8.
Lopez-Huertas MR, Mateos E, Sanchez Del Cojo M, Gomez-Esquer F, Diaz-Gil G, Rodriguez-Mora S, et al. The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production. J Biol Chem. 2013;288(11):7626-44.
Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V,
Hyjek E, Schattner EJ, Cesarman E. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood. 2006;107(8):3295-302.
Lee JY, Nguyen TTN, Myoung J. Zika Virus-Encoded NS2A and NS4A Strongly Downregulate NF-kappaB Promoter Activity. J Microbiol Biotechnol. 2020;30(11):1651-8.
Turpin J, Frumence E, Desprès P, Viranaicken W, Krejbich-Trotot P. The ZIKA Virus Delays Cell Death Through the Anti-Apoptotic Bcl-2 Family Proteins. Cells. 2019;8(11).